# Tetanus Control in the United States and Global Disaster Settings: Public Health Disparities and Prevention Strategies

**Authors:** Olivia Stala, Suhana Patel, Christian Donlon, Syed Shehroz Hussain, Rahim Hirani, Mill Etienne

PMC · DOI: 10.3390/medicina62020338 · 2026-02-07

## TL;DR

This paper reviews tetanus prevention, focusing on disparities in vaccination and risks in disaster zones.

## Contribution

The paper emphasizes tetanus risks in disaster settings and highlights inequities in vaccine access.

## Key findings

- Unvaccinated and under-vaccinated populations remain at high risk for tetanus.
- Disaster zones face increased tetanus vulnerability due to contaminated wounds and disrupted infrastructure.
- Public health strategies must address social and geographic disparities to improve tetanus prevention.

## Abstract

Tetanus, a disease caused by the neurotoxin-producing bacteria Clostridium tetani (C. tetani), remains a serious threat, particularly among individuals who are unvaccinated or under-vaccinated. Although public health guidelines in the United States continue to recommend a well-established, multi-dose vaccination schedule to prevent tetanus, recent revisions to the Centers for Disease Control and Prevention webpage language on vaccine safety prompted renewed public discussion. Despite this, extensive evidence continues to demonstrate the effectiveness and safety of tetanus immunization, and certain demographic groups remain disproportionately at risk. Globally and within the United States, natural disaster zones remain especially high-risk environments for tetanus infection. This review examines the pathophysiology of tetanus, current vaccination recommendations, and the social and geographic inequities that influence vaccine uptake. It also evaluates strategies of protection and prevention. Particular emphasis is placed on tetanus risk in disaster settings, where disrupted infrastructure, greater likelihood of contaminated wounds, and preexisting disparities in vaccination coverage compound vulnerability. A clearer understanding of these factors is essential for strengthening public health preparedness and ensuring equitable protection against tetanus, especially for populations disproportionately affected by disasters.

## Linked entities

- **Diseases:** tetanus (MONDO:0005526)
- **Species:** Clostridium tetani (taxon 1513)

## Full-text entities

- **Diseases:** scalp (MESH:D004476), diphtheria (MESH:D004165), maternal (MESH:D000079262), necrotic (MESH:D009336), muscle rigidity (MESH:D009127), infectious disease (MESH:D003141), acellular pertussis (MESH:D014917), Cephalic tetanus (MESH:D013746), legionellosis (MESH:D007876), , and diarrheal conditions (MESH:D004403), cranial nerve VII palsy (MESH:D005155), muscle spasms (MESH:D013035), runny nose (MESH:D000086722), crush injuries (MESH:D000071576), spastic paralysis (MESH:C538358), death (MESH:D003643), COVID-19 (MESH:D000086382), infections (MESH:D007239), wound infections (MESH:D014946), skin rashes (MESH:D005076), respiratory compromise (MESH:D012131), flooding (MESH:C565009), headaches (MESH:D006261), spasticity (MESH:D009128), injuries (MESH:D014947), muscle contraction (MESH:C536214), C. tetani infection (MESH:D013742), neurotoxicity (MESH:D020258), trismus (MESH:D014313)
- **Chemicals:** Td (MESH:C076628), DTP1 (-), disulfide (MESH:D004220), penicillin (MESH:D010406), benzodiazepines (MESH:D001569), magnesium sulfate (MESH:D008278), acetylcholine (MESH:D000109), GABA (MESH:D005680), glycine (MESH:D005998), zinc (MESH:D015032), Metronidazole (MESH:D008795)
- **Species:** Equus caballus (domestic horse, species) [taxon 9796], Homo sapiens (human, species) [taxon 9606], Petrachloros mirabilis (species) [taxon 2918835], Mus musculus (house mouse, species) [taxon 10090], Clostridium botulinum (species) [taxon 1491], Clostridium tetani (species) [taxon 1513], Human papillomavirus (species) [taxon 10566]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12942225/full.md

---
Source: https://tomesphere.com/paper/PMC12942225